Darolutamide (DARO) in Combination With Androgen-deprivation Therapy (ADT) and Docetaxel (DOC)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer (NCT07031258) | Nanfang Hospital, Southern Medical University | 2025-06-01 |
Track Darolutamide (DARO) in Combination With Androgen-deprivation Therapy (ADT) and Docetaxel (DOC) automatically
Every clearance here is in the API, with alerts when new ones post.